NCT00059930View on ClinicalTrials.gov

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

March 24, 2025

Study Completion Date

March 24, 2025

Conditions
Colorectal CancerMetastatic Cancer
Interventions
DRUG

FOLFOX regimen

DRUG

dexamethasone

DRUG

floxuridine

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

PROCEDURE

adjuvant therapy

PROCEDURE

conventional surgery

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Center, New York

08903

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Medicine and Dentistry of New Jersey

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00059930 - Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer | Biotech Hunter | Biotech Hunter